Kevin Tang is Director at Aurinia Pharmaceuticals Inc. (AUPH). They have made 14 open-market trades across 3 companies since 2024, most recently 2026-08-26.
CIK 0001178579
13 open-market purchases totalling $68.9M since 2024, against 1 sale. Across 11 scored buys the stock is up 0.2% at ninety days, and 3.1 points behind the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| AUPH | 13,044,106 | $215.6M |
| FULC | 7,080,945 | $25.9M |
| BOLD | 2,840,635 | $6.6M |
| Total | $248.1M |
Shares reported on the most recent Form 4, priced at the 2026-08-28 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 54% | 69% | 45% |
| Avg Move | -1.1% | +4.5% | +0.2% |
| Alpha | -0.3% | +4.0% | -3.1% |
| Scored | 13 | 13 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BOLD | SELL | 2026-08-26 | 2026-08-28 | $2.97 | $54K | +0.0% | -8.3% | — |
| BOLD | BUY | 2026-07-17 | 2026-07-21 | $2.44 | $12K | -4.2% | +11.2% | — |
| FULC | BUY | 2026-07-16 | 2026-07-20 | $3.55 | $595K | +2.3% | +7.6% | — |
| BOLD | BUY | 2026-07-14 | 2026-07-16 | $2.43 | $156K | +0.8% | +15.9% | -2.0% |
| FULC | BUY | 2026-07-13 | 2026-07-15 | $3.57 | $891K | +0.4% | +0.8% | -0.7% |
| BOLD | BUY | 2026-07-09 | 2026-07-13 | $2.42 | $222K | +3.3% | +14.6% | +3.7% |
| BOLD | BUY | 2026-07-06 | 2026-07-08 | $2.48 | $142K | -2.2% | +15.3% | +2.2% |
| BOLD | BUY | 2026-06-30 | 2026-07-02 | $2.50 | $269K | -0.4% | +2.2% | -1.0% |
| BOLD | BUY | 2026-06-25 | 2026-06-29 | $2.50 | $715K | -10.2% | -8.6% | -3.2% |
| AUPH | BUY | 2026-05-29 | 2026-06-02 | $15.29 | $12.5M | +0.1% | -1.5% | +1.9% |
| AUPH | BUY | 2026-02-27 | 2026-03-03 | $14.10 | $12.7M | -4.3% | +7.1% | +5.1% |
| AUPH | BUY | 2025-08-01 | 2025-08-05 | $10.45 | $13.6M | +4.4% | +6.6% | +12.1% |
| AUPH | BUY | 2025-02-28 | 2025-03-04 | $7.96 | $16.3M | +0.7% | -0.6% | -1.7% |
| AUPH | BUY | 2024-12-05 | 2024-12-09 | $9.02 | $10.8M | -4.8% | -12.2% | -14.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.